Astrana Health, Inc. (NASDAQ:ASTH – Get Free Report) has been assigned an average rating of “Moderate Buy” from the eight analysts that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and five have given a buy rating to the […]

Shares of X4 Pharmaceuticals, Inc. (NASDAQ:XFOR – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the six brokerages that are presently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating […]